HALO logo
halo search icon
AGN
Argenica Therapeutics Ltd

AGN · Argenica Therapeutics Ltd

0.16

AUD
0.02 (14.29%)
17/07/2026 04:10:11 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$17.98M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 17/07/2026 04:10:11 PM

Price Chart

Description

Argenica Therapeutics Ltd. provides neuroprotective treatment. It specializes in development and commercialization of a novel therapeutic known as ARG-007. It offers drug ARG-007 in multiple models of stroke and other central nervous system (CNS) injury models, specifically: stroke including non-human primates; traumatic brain injury; and perinatal hypoxia ischaemia. The company was founded on November 20, 2019 and is headquartered in Nedlands, Australia.

  • All-Companies
  • Big Candle
  • Big Candle (Realtime)
  • Engulfing Bullish
  • GROWTH AUS
  • HALO Consensus Value
  • HALO Ords
  • Hammer Bearish
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

1.60%

EBITDA Margin

N/A

Operating Cashflow

-$6m

Free Cash Flow Return

-53.80%

ROIC

-67.70%

Interest Coverage

N/A

Quick Ratio

2.90

Performance

52 weeks range

Low 0.09 - 0.77

Trade Value (12mth)

AU$19,955.00

1 week

16.67%

1 month

27.27%

YTD

-54.1%

1 year

-78.95%

All time high

1.02

Additional Data

Shares Outstanding (Fully Diluted)

128m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
16 July 26ASXD
11 June 26ASXD
11 June 26ASXD
11 June 26ASXD
10 June 26ASXD

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Argenica Therapeutics Ltd (AGN:ASX)?
Halo FAQ
The current share price of Argenica Therapeutics Ltd (AGN:ASX) is AUD$0.16.
2
What is the 52-week high share price for Argenica Therapeutics Ltd (AGN:ASX)?
Halo FAQ
The 52-week high share price for Argenica Therapeutics Ltd (AGN:ASX) is AUD$0.77.
3
What is the 52-week low share price for Argenica Therapeutics Ltd (AGN:ASX)?
Halo FAQ
The 52-week low share price for Argenica Therapeutics Ltd (AGN:ASX) is AUD$0.09.
4
What is the dividend yield for Argenica Therapeutics Ltd (AGN:ASX)?
Halo FAQ
Argenica Therapeutics Ltd (AGN:ASX) does not pay a dividend.
5
What was Argenica Therapeutics Ltd (AGN:ASX) last dividend payment?
Halo FAQ
Argenica Therapeutics Ltd (AGN:ASX) does not pay a dividend.
6
What is the franking level for Argenica Therapeutics Ltd (AGN:ASX)?
Halo FAQ
Argenica Therapeutics Ltd (AGN:ASX) has a franking level of 0.00%.
7
In which sector is Argenica Therapeutics Ltd (AGN:ASX) classified?
Halo FAQ
Argenica Therapeutics Ltd (AGN:ASX) is classified in the Healthcare.